• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.57% Nasdaq Down 0.74%

    Geron Corporation (GERN)

    -NasdaqGS
    2.73 Down 0.11(3.88%) 2:30PM EDT - Nasdaq Real Time Price
    Prev Close:2.84
    Open:2.83
    Bid:2.72 x 23000
    Ask:2.73 x 12000
    1y Target Est:7.50
    Beta:2.98355
    Next Earnings Date: 5-May-16GERN Earnings announcement
    Day's Range:2.72 - 2.85
    52wk Range:2.30 - 5.30
    Volume:1,897,533
    Avg Vol (3m):2,405,790
    Market Cap:433.83M
    P/E (ttm):N/A
    EPS (ttm):0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GERN

    Comparison

    Symbol% ChgMkt Cap
    GERNDown 3.88%433.83M
    BMYDown 0.96%117.60B
    GSKDown 1.76%102.56B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.23
    Quarterly EPS Est (Mar-16) :-0.06
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-2.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback